Reshma Kewalramani, CEO & President, Director at Vertex Pharmaceuticals, holds 115.97K shares in Vertex Pharmaceuticals (Ticker: VRTX), holds 186.00K shares in Ginkgo Bioworks Holdings (Ticker: DNA). Most recently, Reshma Kewalramani Bought ― shares of Vertex Pharmaceuticals on Aug 07, 2025 for an estimated value of 3.90M.
What is the percentage of profitable transactions made by Reshma Kewalramani?
The percentage of profitable transactions made by Reshma Kewalramani is ―.
What is the average return per transaction made by Reshma Kewalramani?
The average return per transaction made by Reshma Kewalramani is ―.
What stocks does Reshma Kewalramani hold?
Reshma Kewalramani holds: VRTX, DNA stocks.
What was Reshma Kewalramani’s latest transaction?
Reshma Kewalramani latest transaction was an Informative Buy of $3.90M.
What was Reshma Kewalramani's most profitable transaction?
Reshma Kewalramani’s most profitable transaction was an Informative Buy of VRTX stock on August 23, 2021. The return on the trade was 44.20%.
What is Reshma Kewalramani's role in Vertex Pharmaceuticals?
Reshma Kewalramani's role in Vertex Pharmaceuticals is CEO & President, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.